If vaccine is adjuvanted, how will it be formulated?
Formulation will vary by provider. For Novartis, vaccine may be pre-formulated with adjuvant. For CSL, GSK and Sanofi Pasteur, mixing of vaccine and adjuvant at the site of administration will be necessary. Specific information on storage requirements and procedures for mixing vaccine and adjuvant will be provided by the CDC. Medimmune vaccine will not be adjuvanted.